Norbert W. Bischofberger
Chief Executive Officer bei KRONOS BIO, INC.
Vermögen: 10 Mio $ am 31.03.2024
Profil
Norbert W.
Bischofberger is the founder of Rezo Therapeutics, Inc. (founded in 2022) where he holds the title of Director.
He is currently the President, Chief Executive Officer & Director at Kronos Bio, Inc. (since 2018), an Independent Director at Morphic Holding, Inc. (since 2019), a Director at Morphic Therapeutic, Inc. (since 2019), and an Independent Member-Supervisory Board at Bayer AG (since 2017).
He is also a Scientific Advisor at VV Manager LLC.
Dr. Bischofberger previously worked as a Director at InCarda Therapeutics, Inc. He held the position of Chief Scientific Officer & Executive VP- Research at Gilead Sciences, Inc. from 2007 to 2018.
Prior to that, he was the Manager-DNA Synthesis Group at Genentech, Inc. from 1986 to 1990.
Dr. Bischofberger obtained a doctorate degree from the Swiss Federal Institute of Technology in 1983 and an undergraduate degree from the University of Innsbruck in 1980.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
KRONOS BIO INC
12,39% | 15.02.2024 | 7 445 248 ( 12,39% ) | 10 Mio $ | 31.03.2024 |
MORPHIC HOLDING, INC.
-.--% | 01.06.2023 | 0 ( -.--% ) | - $ | 31.03.2024 |
Aktive Positionen von Norbert W. Bischofberger
| Unternehmen | Position | Beginn |
|---|---|---|
| BAYER AG | Director/Board Member | 01.04.2017 |
| KRONOS BIO, INC. | Chief Executive Officer | 01.08.2018 |
| MORPHIC HOLDING, INC. | Director/Board Member | 01.06.2019 |
Morphic Therapeutic, Inc.
 Morphic Therapeutic, Inc. BiotechnologyHealth Technology Morphic Therapeutic, Inc. engages in biotechnology drug development activity. The company is headquartered in Waltham, MA. | Director/Board Member | 14.06.2019 |
Rezo Therapeutics, Inc.
 Rezo Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Rezo Therapeutics, Inc. is a drug discovery company based in San Francisco, CA. The company's mission is to revolutionize traditional drug development by integrating proteomics, genetics, structural biology, chemistry, artificial intelligence, and machine learning to create maps of molecular disease networks. Rezo's initial focus is on oncology, but they plan to explore additional therapeutic areas through collaborations and partnerships. The company was founded by Natalia Jura, Kevan Shokat, Nevan Krogan, Sourav Bandyopadhyay, Norbert W. Bischofberger, and George A. Scangos, with Nevan Krogan serving as CEO since incorporation. | Founder | 17.11.2022 |
VV Manager LLC
 VV Manager LLC Investment ManagersFinance VV Manager LLC (Vida Ventures) is a venture capital firm founded in 2017 by Arie Belldegrun, Arjun Goyal and Stefan Vitorovic. The firm is headquartered in Boston, Massachusetts. | Consultant / Advisor | - |
Ehemalige bekannte Positionen von Norbert W. Bischofberger
| Unternehmen | Position | Ende |
|---|---|---|
| GILEAD SCIENCES, INC. | Chief Tech/Sci/R&D Officer | 30.04.2018 |
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Corporate Officer/Principal | 01.01.1990 |
InCarda Therapeutics, Inc.
 InCarda Therapeutics, Inc. BiotechnologyHealth Technology InCarda Therapeutics, Inc. develops cardiovascular disease treatment through pulmonary delivery of established drugs. It also develops an inhaled therapy intended to treat paroxysmal atrial fibrillation. The company was founded by Narasimhan Rangachari, John S. Patton, Gregory M. Marcus and Carlos A. Schuler in 2009 and is headquartered in Newark, CA. | Director/Board Member | - |
Ausbildung von Norbert W. Bischofberger
| University of Innsbruck | Undergraduate Degree |
| Swiss Federal Institute of Technology | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 4 |
|---|---|
| GILEAD SCIENCES, INC. | Health Technology |
| BAYER AG | Health Technology |
| MORPHIC HOLDING, INC. | Health Technology |
| KRONOS BIO, INC. | Health Technology |
| Private Unternehmen | 5 |
|---|---|
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Health Technology |
InCarda Therapeutics, Inc.
InCarda Therapeutics, Inc. BiotechnologyHealth Technology InCarda Therapeutics, Inc. develops cardiovascular disease treatment through pulmonary delivery of established drugs. It also develops an inhaled therapy intended to treat paroxysmal atrial fibrillation. The company was founded by Narasimhan Rangachari, John S. Patton, Gregory M. Marcus and Carlos A. Schuler in 2009 and is headquartered in Newark, CA. | Health Technology |
Morphic Therapeutic, Inc.
Morphic Therapeutic, Inc. BiotechnologyHealth Technology Morphic Therapeutic, Inc. engages in biotechnology drug development activity. The company is headquartered in Waltham, MA. | Health Technology |
VV Manager LLC
VV Manager LLC Investment ManagersFinance VV Manager LLC (Vida Ventures) is a venture capital firm founded in 2017 by Arie Belldegrun, Arjun Goyal and Stefan Vitorovic. The firm is headquartered in Boston, Massachusetts. | Finance |
Rezo Therapeutics, Inc.
Rezo Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Rezo Therapeutics, Inc. is a drug discovery company based in San Francisco, CA. The company's mission is to revolutionize traditional drug development by integrating proteomics, genetics, structural biology, chemistry, artificial intelligence, and machine learning to create maps of molecular disease networks. Rezo's initial focus is on oncology, but they plan to explore additional therapeutic areas through collaborations and partnerships. The company was founded by Natalia Jura, Kevan Shokat, Nevan Krogan, Sourav Bandyopadhyay, Norbert W. Bischofberger, and George A. Scangos, with Nevan Krogan serving as CEO since incorporation. | Commercial Services |
